Smith Group Asset Management, LLC Merck & Co., Inc. Transaction History

Smith Group Asset Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 30, 2024	SELL	$123.8 - $132.96 $2.79 Million - $2.99 Million	-22,521 Reduced 13.62%	142,821 $17.7 Billion
Q1 2024 Apr 30, 2024	BUY	$113.24 - $131.95 $354,667 - $413,267	3,132 Added 1.93%	165,342 $21.8 Billion
Q4 2023 Feb 12, 2024	SELL	$100.18 - $109.02 $20.8 Million - $22.7 Million	-208,052 Reduced 56.19%	162,210 $17.7 Billion
Q1 2022 May 05, 2022	SELL	$73.51 - $82.4 $1.16 Million - $1.31 Million	-15,840 Reduced 4.1%	370,262 $30.4 Million
Q4 2021 Feb 02, 2022	BUY	$72.28 - $90.54 $14.6 Million - $18.3 Million	202,304 Added 110.07%	386,102 $29.6 Million
Q3 2021 Nov 12, 2021	BUY	$71.68 - $78.83 $13.2 Million - $14.5 Million	183,798 New	183,798 $13.8 Million

3,824

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $261B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Smith Group Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Smith Group Asset Management, LLC with notifications on news.